Valuebridge Energy Group

Agile Defense, headquartered in Reston, VA, is a leading innovator in providing advanced capabilities and solutions tailored to critical national security and civilian missions. The company specializes in digital transformation, data analytics, and cybersecurity, employing a data-driven approach to safeguard sensitive assets against emerging threats. With a commitment to innovation and leveraging the latest technologies, Agile Defense operates globally across North America, Europe, Asia, and the Middle East. Their Agile Labs foster a culture of exploration and collaboration, ensuring that they consistently deliver specialized solutions that enhance mission effectiveness. Generated from the website

Juice is a full-service partner specializing in creating revenue-generating analytics solutions, offering expertise and a proprietary platform to transform data into valuable products that drive growth. With a focus on rapid time to market, seamless integration, and cost-effective growth, Juice stands out as a trusted industry leader across various sectors. Leveraging decades of experience in designing and launching customer-facing analytical products, Juice helps clients differentiate in the market with visual, interactive solutions that prioritize user experience. From industry benchmarking to predictive models and data-driven sales enablement, Juice empowers businesses to tell compelling stories with data and elevate their data visualizations for impactful results. Generated from the website

DrugLogic Inc, based in Reston, VA, specializes in developing analytical tools and enterprise process support systems aimed at managing risks associated with drug safety issues. Their proprietary Qscan product offers innovative solutions for monitoring patient adverse event claims and outcomes, enhancing drug safety surveillance practices for healthcare and pharmaceutical enterprises. In collaboration with the General Practice Research Database (GPRD), DrugLogic provides a version of GPRD that integrates with its Qscan analysis software, enabling users to conduct in-depth analyses of anonymized electronic health records. This partnership facilitates a comprehensive understanding of drug behaviors and post-market patient reactions, contributing to improved pharmacovigilance and risk management strategies. Generated from the website